Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Newman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Vascular and Interventional Radiology : JVIR|November 27, 2009
Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survivalBrian L Dunfee, Ahsun Riaz, Robert J Lewandowski, et al.
Nature|April 10, 2015
Recovery potential of the world's coral reef fishesM Aaron MacNeil, Nicholas A J Graham, Joshua E Cinner, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 15, 2007
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survivalAffaan K Bangash, Bassel Atassi, Virginia Kaklamani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survivalAhsun Riaz, Robert K Ryu, Laura M Kulik, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesKhairuddin Memon, Robert J Lewandowski, Mary F Mulcahy, et al.
Gastroenterology|November 4, 2010
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinomaRiad Salem, Robert J Lewandowski, Laura Kulik, et al.
Cell Reports. Medicine|March 1, 2024
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trialPatrick Yu-Wai-Man, Valerio Carelli, Nancy J Newman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Vascular and Interventional Radiology : JVIR|November 27, 2009
Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survivalBrian L Dunfee, Ahsun Riaz, Robert J Lewandowski, et al.
Nature|April 10, 2015
Recovery potential of the world's coral reef fishesM Aaron MacNeil, Nicholas A J Graham, Joshua E Cinner, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 15, 2007
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survivalAffaan K Bangash, Bassel Atassi, Virginia Kaklamani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survivalAhsun Riaz, Robert K Ryu, Laura M Kulik, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesKhairuddin Memon, Robert J Lewandowski, Mary F Mulcahy, et al.
Gastroenterology|November 4, 2010
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinomaRiad Salem, Robert J Lewandowski, Laura Kulik, et al.
Cell Reports. Medicine|March 1, 2024
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trialPatrick Yu-Wai-Man, Valerio Carelli, Nancy J Newman, et al.
Pageof 2